WASHINGTON, July 24 -- The U.S. Department of Health and Human Services, through the Food and Drug Administration, has announced a funding opportunity titled Applied Regulatory Science Research to Evaluate Cardiotoxicity of Oncology Therapeutics (U01) Clinical Trial Optional. This initiative intends to support applied regulatory science research that focuses on improving the detection and monitoring of cardiotoxic side effects associated with cancer treatments. With an award ceiling of $500,000 more ST

WASHINGTON, July 24 -- The U.S. Department of Health and Human Services, through the Food and Drug Administration, has announced the availability of funding aimed at addressing critical drug shortages. The initiative, titled Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities, offers a total of $6 million across two anticipated awards, with each award reaching a ceiling of $3 million. This funding opportunity focuses on enhancing the understandi more ST